Clinical trial Recruiting at 1 site Interventional Ages 18 and up

Live online group exercise for cancer survivors

Official title: Efficacy of a Group-based Videoconference Intervention to Increase Physical Activity in Cancer Survivors

Run by Colorado State University · NCT07290309 · Data updated 2026-11-12

This trial will test whether live online group exercise helps people who have finished primary cancer treatment become more active, fitter, and less lonely compared with prerecorded exercise videos.

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment300 (estimated)
SponsorColorado State University
Academic / other
Drugs / interventionschemotherapy, radiation
Locations1 site (Fort Collins, Colorado)
StatusRecruiting
StartedFebruary 6, 2026
Main results expectedDecember 1, 2029
Study endsMarch 1, 2030
Registry record updatedMarch 31, 2026
Trial IDNCT07290309 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults diagnosed with any type of cancer within the last five years who have completed primary or adjuvant treatment, can read and speak English, are not currently doing ≥150 minutes per week of moderate exercise, and have no medical contraindications for moderate-to-vigorous exercise.

Probably not a fit

People already meeting 150+ minutes per week of moderate exercise, those with contraindications to unsupervised moderate-to-vigorous exercise, those planning cancer treatment within nine months, or those unable to participate in English or attend required assessments may not benefit or be ineligible.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This interventional study compares live, supervised group exercise delivered by videoconference with asynchronous recorded exercise sessions for people living with and beyond cancer. The program targets moderate-to-vigorous aerobic and resistance activity and incorporates behavior-change techniques like goal setting, social support, and self-monitoring. Outcomes include minutes of MVPA, aerobic endurance, muscular strength, quality of life, and loneliness, and the study will explore mediators and moderators such as self-efficacy and neighborhood walkability. Measurements are taken at baseline and at defined follow-up timepoints with a mix of remote delivery and supervised assessments.

Why it matters

Potential benefit: If successful, the live online group sessions could help survivors increase weekly moderate-to-vigorous activity, improve fitness and quality of life, and reduce feelings of loneliness.

How similar studies have gone: Supervised, group-based exercise programs have shown clear benefits for cancer survivors, while remotely delivered interventions show promise but generally produce smaller effects, making virtual group exercise a growing but not fully established approach.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Able to speak/read English,
* Diagnosed with any type of cancer within the last 5 years
* Completed primary or adjuvant treatment (i.e., chemotherapy, radiation therapy, surgery) with no planned treatment within the next nine months. This does not include long-term or chronic therapies such as anti-hormone or targeted therapies (e.g., aromatase inhibitor, androgen deprivation therapy, immunotherapies)

Exclusion Criteria:

* Existing participation in ≥150 minutes per week of at least moderate intensity aerobic exercise
* Known contraindications for non-medically supervised moderate or greater intensity exercise (e.g., uncontrolled hypertension, inability to walk without an assistive device)
* Current or planned participation in another structured program or intervention intended to encourage participation in exercise or physical activity.

Where it's running

  • Human Performance Clinical Research Lab
    Fort Collins, Colorado, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.